韩国移植队列中肾衰竭的遗传景观:全基因组关联与多基因风险评分分析
该研究在2355例肾衰竭患者(三种亚型)和152131例对照中开展全基因组关联研究,发现多个与肾衰竭及其亚型相关的遗传位点,并构建多基因风险评分模型,显示其预测性能优于基础临床因素,且肾衰竭遗传结构与CKD不同。
要点
- 全基因组关联研究识别出肾衰竭及亚型特异性位点,如HLA-DRB1和COL24A1。
- 多基因风险评分模型可改善肾衰竭风险预测,优于基础临床因素。
- 肾衰竭遗传结构不同于以肾功能性状为主的CKD。
核心结论
- 本研究识别了肾衰竭亚型特异性遗传位点,并证明多基因风险评分模型能超越基础临床因素改善肾衰竭风险预测。
研究设计与样本
- 研究纳入2355例肾衰竭患者(按原发病分为三种亚型)和152131例对照,进行大规模全基因组关联研究,并计算2型糖尿病、高血压、eGFR和CKD的多基因风险评分,构建多基因风险评分模型。
主要发现
- 全基因组关联研究识别出多个肾衰竭相关位点,包括全肾衰竭和肾小球肾炎的HLA-DRB1以及高血压性肾衰竭的COL24A1,达到全基因组显著性(P < 5×10^-8)。
- 多基因风险评分分析显示2型糖尿病、高血压、CKD和eGFR的遗传组分与各亚型肾衰竭风险显著相关(OR=1.1-2.5)。
- 联合多基因风险评分模型预测性能更优(OR=1.5-2.5)。
- 与主要受eGFR遗传影响的CKD队列比较,发现肾衰竭独特的遗传特征,提示肾衰竭是遗传异质性的多因素疾病。
临床怎么用
- 多基因风险评分模型可用于肾衰竭风险分层,辅助识别高风险个体。
- 肾衰竭遗传结构不同于CKD,临床评估需考虑其多因素遗传背景。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: Genome-wide association study identified multiple genetic loci associated with kidney failure and its subtypes in Korean cohorts. Multiple polygenic risk scores improved the prediction of kidney failure beyond basic available clinical factors. Genetic architecture of kidney failure differed from that of CKD driven mainly by kidney function traits. BACKGROUND: Kidney failure represents the final, irreversible stage of CKD, yet its genetic architecture remains incompletely defined compared with CKD. Although previous studies largely focused on kidney function traits, the genetic determinants of kidney failure itself and its etiologic subtypes are poorly understood. Therefore, this study aimed to identify genetic loci associated with kidney failure and its subtypes and to evaluate the predictive performance of multiple polygenic risk scores (multi-PRSs) for stratifying kidney failure risk. METHODS: We performed a large-scale genome-wide association study using a dataset of 2355 patients with kidney failure across three subtypes defined by primary disease, along with 152,131 controls. Polygenic risk scores for type 2 diabetes, hypertension, eGFR, and CKD were calculated, and a multi-PRS model was derived. RESULTS: The genome-wide association study identified multiple kidney failure-associated loci, including HLA-DRB1 for all kidney failure and glomerulonephritis as the primary disease, and COL24A1 for hypertensive kidney failure at genome-wide significance ( P < 5×10 -8 ), implicating distinct immune- and hypertension-related pathways in kidney failure pathogenesis. Polygenic risk score analysis revealed that genetically distinct components of type 2 diabetes, hypertension, CKD, and eGFR were significantly linked to kidney failure risk across subtypes (odds ratio=1.1-2.5). A combined multi-PRS model demonstrated superior predictive performance (odds ratio=1.5-2.5). Comparison with CKD cohorts, predominantly influenced by eGFR-related genetics, uncovered unique kidney failure-specific genetic signatures, highlighting kidney failure as a genetically heterogeneous and multifactorial disease beyond CKD. CONCLUSIONS: This study identified subtype-specific genetic loci and demonstrated that multi-PRS models improve kidney failure risk prediction beyond basic available clinical factors.
引用
- Jeon HJ, Jang HM, Park YS, et al. Genetic Landscape of Kidney Failure in a Korean Transplant Cohort: Genome-Wide Association and Multi-Polygenic Risk Score Analyses. J Am Soc Nephrol. 2026. PMID: 42302843. doi:10.1681/ASN.0000001168
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。